Cargando…
Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
BACKGROUND: There is high co-occurrence of substance use disorders (SUD) and mental health disorders. We aimed to assess impact of substance use patterns and sociodemographic factors on mental health distress using the ten-item Hopkins Symptom Checklist (SCL-10) over time. METHODS: Nested prospectiv...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912462/ https://www.ncbi.nlm.nih.gov/pubmed/33639969 http://dx.doi.org/10.1186/s13011-021-00354-1 |
_version_ | 1783656582528106496 |
---|---|
author | Aas, Christer Frode Vold, Jørn Henrik Gjestad, Rolf Skurtveit, Svetlana Lim, Aaron Guanliang Gjerde, Kristian Varden Løberg, Else-Marie Johansson, Kjell Arne Fadnes, Lars Thore |
author_facet | Aas, Christer Frode Vold, Jørn Henrik Gjestad, Rolf Skurtveit, Svetlana Lim, Aaron Guanliang Gjerde, Kristian Varden Løberg, Else-Marie Johansson, Kjell Arne Fadnes, Lars Thore |
author_sort | Aas, Christer Frode |
collection | PubMed |
description | BACKGROUND: There is high co-occurrence of substance use disorders (SUD) and mental health disorders. We aimed to assess impact of substance use patterns and sociodemographic factors on mental health distress using the ten-item Hopkins Symptom Checklist (SCL-10) over time. METHODS: Nested prospective cohort study of 707 participants with severe SUD across nine opioid-agonist-therapy outpatient clinics and low-threshold municipality clinics in Norway, during 2017–2020. Descriptive statistics were derived at baseline and reported by means and standard deviation (SD). A linear mixed model analysis was used to assess the impact of substance use patterns and sociodemographic factors on SCL-10 sum score with beta coefficients with 95% confidence intervals (CI). RESULTS: Mean (SD) SCL-10 score was 2.2 (0.8) at baseline with large variations across patients. We observed more symptoms of mental health disorders among people with frequent use of benzodiazepines (beta 3.6, CI:2.4;4.8), cannabis (1.3, CI:0.2;2.5), opioids (2.7, CI:1.1;4.2), and less symptoms among people using frequent stimulant use (− 2.7, CI:-4.1;-1.4) compared to no or less frequent use. Females (1.8, CI:0.7;3.0) and participants with debt worries (2.2, CI:1.1;3.3) and unstable living conditions (1.7, CI:0.0;3.3) had also higher burden of mental health symptoms. There were large individual variations in SCL-10 score from baseline to follow-up, but no consistent time trends indicating change over time for the whole group. 65% of the cohort had a mean score > 1.85, the standard reference score. CONCLUSIONS: People with SUD have a considerable burden of mental health symptoms. We found no association between substance use patterns and change in mental health symptoms over time. This could suggest that the differences observed were indicating flattening of effects or self-medication to a larger degree than medication-related decline in mental health. This call for better individualized mental health assessment and patient care. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13011-021-00354-1. |
format | Online Article Text |
id | pubmed-7912462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79124622021-03-02 Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway Aas, Christer Frode Vold, Jørn Henrik Gjestad, Rolf Skurtveit, Svetlana Lim, Aaron Guanliang Gjerde, Kristian Varden Løberg, Else-Marie Johansson, Kjell Arne Fadnes, Lars Thore Subst Abuse Treat Prev Policy Research BACKGROUND: There is high co-occurrence of substance use disorders (SUD) and mental health disorders. We aimed to assess impact of substance use patterns and sociodemographic factors on mental health distress using the ten-item Hopkins Symptom Checklist (SCL-10) over time. METHODS: Nested prospective cohort study of 707 participants with severe SUD across nine opioid-agonist-therapy outpatient clinics and low-threshold municipality clinics in Norway, during 2017–2020. Descriptive statistics were derived at baseline and reported by means and standard deviation (SD). A linear mixed model analysis was used to assess the impact of substance use patterns and sociodemographic factors on SCL-10 sum score with beta coefficients with 95% confidence intervals (CI). RESULTS: Mean (SD) SCL-10 score was 2.2 (0.8) at baseline with large variations across patients. We observed more symptoms of mental health disorders among people with frequent use of benzodiazepines (beta 3.6, CI:2.4;4.8), cannabis (1.3, CI:0.2;2.5), opioids (2.7, CI:1.1;4.2), and less symptoms among people using frequent stimulant use (− 2.7, CI:-4.1;-1.4) compared to no or less frequent use. Females (1.8, CI:0.7;3.0) and participants with debt worries (2.2, CI:1.1;3.3) and unstable living conditions (1.7, CI:0.0;3.3) had also higher burden of mental health symptoms. There were large individual variations in SCL-10 score from baseline to follow-up, but no consistent time trends indicating change over time for the whole group. 65% of the cohort had a mean score > 1.85, the standard reference score. CONCLUSIONS: People with SUD have a considerable burden of mental health symptoms. We found no association between substance use patterns and change in mental health symptoms over time. This could suggest that the differences observed were indicating flattening of effects or self-medication to a larger degree than medication-related decline in mental health. This call for better individualized mental health assessment and patient care. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13011-021-00354-1. BioMed Central 2021-02-27 /pmc/articles/PMC7912462/ /pubmed/33639969 http://dx.doi.org/10.1186/s13011-021-00354-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Aas, Christer Frode Vold, Jørn Henrik Gjestad, Rolf Skurtveit, Svetlana Lim, Aaron Guanliang Gjerde, Kristian Varden Løberg, Else-Marie Johansson, Kjell Arne Fadnes, Lars Thore Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway |
title | Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway |
title_full | Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway |
title_fullStr | Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway |
title_full_unstemmed | Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway |
title_short | Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway |
title_sort | substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in norway |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912462/ https://www.ncbi.nlm.nih.gov/pubmed/33639969 http://dx.doi.org/10.1186/s13011-021-00354-1 |
work_keys_str_mv | AT aaschristerfrode substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway AT voldjørnhenrik substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway AT gjestadrolf substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway AT skurtveitsvetlana substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway AT limaaronguanliang substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway AT gjerdekristianvarden substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway AT løbergelsemarie substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway AT johanssonkjellarne substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway AT fadneslarsthore substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway AT substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway |